Project Details
Description
The impact of SL-401 on the molecular mechanisms of self-renewal in TP53 mutant AML
Status | Finished |
---|---|
Effective start/end date | 5/12/20 → 5/11/22 |
Funding
- STEMLINE THERAPEUTICS, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.